mRNA |
HLI 373 |
CTRPv2 |
pan-cancer |
AAC |
0.056 |
0.1 |
mRNA |
AZD6482 |
CTRPv2 |
pan-cancer |
AAC |
-0.057 |
0.1 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.058 |
0.1 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.055 |
0.1 |
mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.055 |
0.1 |
mRNA |
Oxaliplatin |
CTRPv2 |
pan-cancer |
AAC |
0.05 |
0.1 |
mRNA |
nelarabine |
CTRPv2 |
pan-cancer |
AAC |
0.058 |
0.1 |
mRNA |
bendamustine |
CTRPv2 |
pan-cancer |
AAC |
0.057 |
0.1 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.051 |
0.1 |
mRNA |
NSC632839 |
CTRPv2 |
pan-cancer |
AAC |
-0.051 |
0.1 |